Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies

mRNA based vaccines against COVID-19 have proven most successful at keeping SARS-CoV-2 pandemic at bay in many countries. Recently, there is an increased interest in heterologous prime-boost vaccination strategies for COVID-19 to maintain antibody responses for the control of continuously emerging S...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Frontiers in immunology Jg. 13; S. 864718
Hauptverfasser:	Vogt, Anne-Cathrine S., Jörg, Lukas, Martina, Byron, Krenger, Pascal S., Chang, Xinyue, Zeltins, Andris, Vogel, Monique, Mohsen, Mona O., Bachmann, Martin F.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Switzerland Frontiers Media S.A 16.06.2022
Schlagworte:	2019-nCoV Vaccine mRNA-1273 COVID-19 COVID-19 - prevention & control COVID-19 Vaccines Humans Immunoglobulin G Immunology mRNA RNA, Messenger - genetics SARS-CoV-2 SARS-CoV-2 - genetics vaccine virus-like particles COVID-19 virus-like particles SARS-CoV-2 vaccine mRNA
ISSN:	1664-3224, 1664-3224
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!